COPD News

Stiolto Respimat helped improve quality of life and lung function in patients with COPD, according to study results.

A low maximal expiratory flow at 50% of forced vital capacity helped predict risks for respiratory symptoms in patients without spirometry-confirmed COPD, according to study results.

The risk for cardiovascular disease appeared to more than double in patients with COPD compared with patients without the disease, according to study results.

Psychological disorders such as depression and anxiety appeared associated with higher 30-day hospital readmission rates in Medicare beneficiaries with COPD, according to study results.

There appeared to be a high prevalence of asthma-COPD overlap syndrome in patients with asthma who had a lengthy smoking history but no previous diagnosis of COPD, according to study results.

A significant number of patients with COPD appeared unaware of the risk factors associated with the disease and had limited knowledge of the current stage of their disease, according to a national survey conducted by Health Union.

Patients with COPD had decreased gray matter volume in anterior, mid, and posterior cingulate cortex, hippocampus and amygdala in the absence of generalized cortical degeneration, according to study results.

Adherium Limited and AstraZeneca have agreed to partner to combine digital health technology with the use of inhaler medications, according to a company press release.

Low circulating concentrations of the anti-inflammatory protein CC16 is a predictor for accelerated lung function decline and incident COPD in adults, according to study results.

The FDA has granted Propeller Health 501(k) clearance to market its Propeller platform in association with GlaxoSmithKline’s Diskus dry powder inhaler device for asthma and COPD, according to a company press release.